-
1.发明授权
公开(公告)号：EP1474158B1
公开(公告)日：2009-10-14
申请号：EP02805203.3
申请日：2002-12-18
CPC分类号： A61K31/7024 , A61K31/00 , A61K31/26
摘要： The present invention generally relates to the field of treating oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathione or intracelluar levels of at least one Phase II detoxification enzyme in animal tissue. The present invention also relates to the field of protecting a subject from photooxidation or oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathione or intracellular levels of at least one Phase II detoxification enzyme in the subject. The present invention also relates to a pharmaceutical composition useful for the treatment of oxidative stress disorders.
-
2.发明公开PREVENTION AND TREATMENT OF OXIDATIVE STRESS DISORDERS BY GLUTATHIONE AND PHASE II DETOXIFICATION ENZYMES 有权预防和氧化应激疾病治疗链接到细胞内谷胱甘肽镜或相位II解毒酶增加
公开(公告)号：EP1474158A2
公开(公告)日：2004-11-10
申请号：EP02805203.3
申请日：2002-12-18
CPC分类号： A61K31/7024 , A61K31/00 , A61K31/26
摘要： The present invention generally relates to the field of treating oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathione or intracelluar levels of at least one Phase II detoxification enzyme in animal tissue. The present invention also relates to the field of protecting a subject from photooxidation or oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathione or intracellular levels of at least one Phase II detoxification enzyme in the subject. The present invention also relates to a pharmaceutical composition useful for the treatment of oxidative stress disorders.
-
搜索结果
2 条记录 (耗时 0.009 秒)
